Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ettore Mosca

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Frontiers in Cellular Neuroscience|December 6, 2021
Transmembrane Protein TMEM230, a Target of Glioblastoma TherapyCinzia Cocola, Valerio Magnaghi, Edoardo Abeni, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2013
Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasisGiuseppe Vezzoli, Annalisa Terranegra, Andrea Aloia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Elena Riva, Luca Lanino, et al.
Blood|June 14, 2021
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Manja Meggendorfer, Matteo Zampini, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Frontiers in Cellular Neuroscience|December 6, 2021
Transmembrane Protein TMEM230, a Target of Glioblastoma TherapyCinzia Cocola, Valerio Magnaghi, Edoardo Abeni, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2013
Decreased transcriptional activity of calcium-sensing receptor gene promoter 1 is associated with calcium nephrolithiasisGiuseppe Vezzoli, Annalisa Terranegra, Andrea Aloia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2021
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic SyndromesMatteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2025
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic SyndromesMatteo Zampini, Elena Riva, Luca Lanino, et al.
Blood|June 14, 2021
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Manja Meggendorfer, Matteo Zampini, et al.
Pageof 6